Posts by SharpBrains
Time for a universal “exercise prescription” for kids and adults to boost cognition and mental health?
Welcome to a new edition of SharpBrains e‑newsletter, featuring this time a range of brain research findings, tools and controversies plus some brain teasers to challenge your (and our) working memory. #1. Major evidence review supports an “exercise prescription” for most adults to boost mental health “Higher intensity physical activity was associated with greater improvements”…
Read MorePrice tag for a questionable Alzheimer’s treatment: $109,000 per patient, per year. Unclear yet: For how many years?
The real costs of the new Alzheimer’s drug, Leqembi — and why taxpayers will foot much of the bill (CBS News): The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors…
Read MoreJust-published Apple patent signals aim to measure brain activity using AirPods sensor system
Apple Invents a next-generation AirPods Sensor System that could measure Biosignals and Electrical Activity of a User’s brain (Patently Apple): Today the US Patent & Trademark Office published a patent application from Apple that relates to a next-generation of AirPods Sensor System wherein the housing and tips of AirPods could include a number of active and…
Read MoreVirtual cognitive behavioural therapy (CBT) accounts for over 30% of NHS mental health treatments — up from 10% in 2017
Concern as a third of NHS mental health treatments shift online (The Guardian): An Observer analysis of data from private providers, cross-checked against NHS figures, reveals around one in three mental health treatments in England are delivered online, up from one in five in 2019, and one in 10 in 2017. Patients with mild to…
Read MoreShould doctors prescribe Leqembi (lecanemab) to women with early Alzheimer’s Disease? The evidence-based answer is probably No
Welcome to a new edition of SharpBrains e‑newsletter, featuring this time a range of interventions for brain/ cognitive/ mental health plus a few brain teasers to test our perception and cognitive skills. #1. Should doctors prescribe lecanemab (Leqembi) to women? The answer, given available evidence, is probably No Huge (and mostly overlooked) red flag regarding newly…
Read MoreGrowing controversy over role of FDA and Medicare in promoting anti-amyloid drugs given limited benefit, high cost, severe side-effects
The War Over Whether Medicare Should Pay For The New Anti-Alzheimer’s Drugs (Forbes): The powerful Alzheimer’s Disease lobby is fighting a multi-billion-dollar battle on two fronts. It is quietly trying to limit restrictions the Food and Drug Administration puts on the use of new drugs aimed at slowing the progression of the brain disease. And…
Read More